8th Drug Formulation and Bioavailability
March 25 - 27, 2019 - Boston NY USScott Grossman
sgrossman@exlevents.com
Phone:0000000000
While still facing evergreen problems with API solubility, formulation professionals are finding new areas for growth in immuno-oncology, regenerative therapies, and controlled release delivery. And beyond purely technical questions, in an increasingly connected workplace the need for improved teamwork is stronger than ever. ExL's 8th Drug Formulation, Solubility and Bioavailability conference is a unique strategic forum where RandD professionals gather to review and rank the latest technological options for drug formulation and delivery, while also bridging the gaps of understanding that may exist between team members. Top Five Reasons to Attend 1. Focus on stronger teamwork between formulation and medicinal chemistry 2. New insights on continuous manufacturing during early development 3. Improved drug delivery options for immuno-oncology and regenerative medicines 4. Innovative CNS delivery methods across the blood-brain barrier 5. Strategies to select the least painful drug delivery methods **FULL-DAY INTERACTIVE SEMINAR about the development and modeling of amorphous solid dispersions! Featuring in-depth discussions of shelf-life and toxicology challenges, outsourcing decisions, development for nanoparticles and generics - and much more!